# FDA 483 - Mobeen Mazhar, M.D. - April 28, 2022

Source: https://www.globalkeysolutions.net/records/483/mobeen-mazhar-md/98c4b021-5e70-4278-8892-13db68560eb5

> FDA 483 for Mobeen Mazhar, M.D. on April 28, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mobeen Mazhar, M.D.
- Inspection Date: 2022-04-28
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Mobeen Mazhar, M.D., Clinical Investigator, revealed significant non-compliance with clinical investigation protocols. The firm failed to properly conduct the study, report adverse events, and maintain adequate investigational drug disposition records. These issues indicate serious deficiencies in the oversight and execution of the clinical trial.

## Related Documents

- [WARNING_LETTER - 2022-04-28](https://www.globalkeysolutions.net/records/warning_letter/mobeen-mazhar-md/5bcfb37f-8dc6-4993-9173-295475aadd0d)

## Related Officers

- [CSO](https://www.globalkeysolutions.net/people/andrea-a-branche/9ffe9b53-7963-49a6-be4e-25e644f1759f)

Company: https://www.globalkeysolutions.net/companies/mobeen-mazhar-md/1557dc9b-1b47-4657-b1f2-c3ecb53b112a

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab